Sanofi
ENXTPA:SAN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 150 Fair Values set on narratives written by author
WA
Consensus Narrative from 22 Analysts
Dupixent's Expansion And New Medicines Will Improve Global Healthcare Solutions
Key Takeaways Strong performance in new medicines and Dupixent's market expansion boosts Sanofi's revenue growth and addresses unmet medical needs globally. Strategic acquisitions and operational efficiency enhance net margins, bolster consumer health presence, and optimize capital structure for EPS growth.
View narrative€114.57
FV
9.1% undervalued intrinsic discount2.58%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
23 days ago author updated this narrative